IMPLANT SITE DERMATITIS

This adverse event was reported 18 times

These drugs are most commonly taken by patients reporting IMPLANT SITE DERMATITIS:

# Drug Count
0 ETONOGESTREL 10
1 HISTRELIN ACETATE 2
2 CARBOPLATIN 1
3 CITALOPRAM 1
4 CITALOPRAM HYDROBROMIDE 1
5 ECULIZUMAB 1
6 PEGFILGRASTIM 1
See all common drugs associated with IMPLANT SITE DERMATITIS

IMPLANT SITE DERMATITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 HISTRELIN ACETATE 2 0.0023
1 ETONOGESTREL 10 0.0002
2 PEGFILGRASTIM 1 0.0001
3 ECULIZUMAB 1 0.0000
4 CARBOPLATIN 1 0.0000
5 CITALOPRAM 1 0.0000
See all drugs enriched for association with IMPLANT SITE DERMATITIS

These drug classes are most commonly taken by patients reporting IMPLANT SITE DERMATITIS:

# Drug class Count
0 Progestin [EPC] 10
1 Complement Inhibitor [EPC] 1
2 Leukocyte Growth Factor [EPC] 1
3 Platinum-based Drug [EPC] 1
4 Serotonin Reuptake Inhibitor [EPC] 1
See all common drug classes associated with IMPLANT SITE DERMATITIS

IMPLANT SITE DERMATITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Progestin [EPC] 10 0.0000
1 Complement Inhibitor [EPC] 1 0.0000
2 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
3 Leukocyte Growth Factor [EPC] 1 0.0000
4 Platinum-based Drug [EPC] 1 0.0000
See all drug classes enriched for association with IMPLANT SITE DERMATITIS